Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

885218

registered interest
date	17/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of people of working age in England with (a) Parkinson’s disease, (b) cystic fibrosis, (c) sickle cell anaemia and (d) Lupus have to pay for their prescriptions.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	136083
answer	answer is ministerial correction date of answer 25/04/2018 answer text <p>The Department does not hold this information. Extensive arrangements are in place to ensure that people can access affordable prescriptions and almost 90% of prescription items are free on the National Health Service in England. Individuals may be exempted on the basis of medical conditions or may be entitled to exemption on the basis of their age or income. To support those who do not qualify for an exemption, Prescription Prepayment Certificates are available, which allow holders to get all the prescriptions they require for just £2 per week.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/04/2018 11:00:17 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

885220

registered interest
date	17/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the Government's commissioned analysis by Ernst and Young of the effect of the UK leaving the EU on the medicines supply chain.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	136085
answer	answer is ministerial correction date of answer 25/04/2018 answer text <p>Due to the large volume of commercial and sensitive information that has been shared by the pharmaceutical industry throughout this work, the Department will be unable to publish the final report. However, we will consider publication of an executive summary of the work.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/04/2018 10:58:31 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

885233

registered interest
date	17/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sapropterin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under Secretary of State for Mental Health and Inequalities on 22 March, Col 488, what recent discussions he has had with BioMarin, the manufacturer of Kuvan, on the pricing of that drug.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	136098
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>NHS England has advised that they have, over the last three years, received fewer than 10 Individual Funding Requests applications and therefore there have been fewer than 10 approvals relating to the use of Kuvan.</p><p> </p><p>The Secretary of State for Health and Social Care has not had further recent discussions with the manufacturer (BioMarin) since the oral contribution of my Rt. hon. Friend the Parliamentary Under Secretary of State for Mental Health and Inequalities (Jackie Doyle-Price).</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136042 question first answered 24/04/2018 15:36:59 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

884929

registered interest
date	16/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much his Department has spent on campaigns to promote the cessation of smoking in (a) 2016-17 and (b) 2017-18; and what funding he plans to allocate to such campaigns in 2018-19.
tabling member constituency	Harrow East
tabling member printed	Bob Blackman
uin	135917
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>Expenditure on smoking cessation advertising media by Public Health England (PHE) in 2016-17 was £1,520,000.</p><p> </p><p>The projected expenditure for smoking cessation campaigns for PHE campaigns in 2017-18 is £2,060,000. Figures for 2017-18 are provisional at this stage. A final amount will be available later in the year once all accounts have been finalised.</p><p> </p><p>Detailed planning is underway for 2018-19 smoking cessation campaigns; therefore at this stage advertising media allocations are not yet available.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:38:54 answering member 4067 label Biography information for Steve Brine
tabling member	4005 label Biography information for Bob Blackman

885054

registered interest
date	16/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sapropterin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many individual patient funding requests have been approved for the use of Kuvan.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	136042
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>NHS England has advised that they have, over the last three years, received fewer than 10 Individual Funding Requests applications and therefore there have been fewer than 10 approvals relating to the use of Kuvan.</p><p> </p><p>The Secretary of State for Health and Social Care has not had further recent discussions with the manufacturer (BioMarin) since the oral contribution of my Rt. hon. Friend the Parliamentary Under Secretary of State for Mental Health and Inequalities (Jackie Doyle-Price).</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136098 question first answered 24/04/2018 15:36:59 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

885057

registered interest
date	16/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Whittington Hospital
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations he has received on the reopening to new patients of the Lower Urinary Tract Services Clinic in north London.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	136045
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>A search of the Department’s Ministerial correspondence database has identified 56 items of correspondence received since 1 April 2017 about the Lower Urinary Tract Services Clinic in north London. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p> </p><p>The Trust has been working to address the recommendations of the Royal College of Physicians following a service review of the Lower Urinary Tract Service, before the clinic is re-opened to new patients. The Trust is currently in negotiations with commissioners to establish the re-opening of the clinic in the 2018/19 contract.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:39:50 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

885058

registered interest
date	16/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Urinary Tract Infections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the annual cost to the NHS of treating chronic urinary tract infections.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	136046
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>This information is not collected.</p><p> </p><p>Clinical commissioning groups provide an estimate of their overall expenditure on problems of the genitourinary system in their annual Programme Budgeting data submission to NHS England. The aggregate value of these estimates was £3,146 million in financial year 2016/17.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:38:00 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

885070

registered interest
date	16/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lyme Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage NHS England to develop specialist services for Lyme disease patients.
tabling member constituency	East Devon
tabling member printed	Sir Hugo Swire
uin	136058
answer	answer is ministerial correction date of answer 19/04/2018 answer text <p>Lyme disease is a bacterial infection and most people recover completely with prompt antibiotic treatment that reduces the risk of further symptoms developing and increases the chance of complete recovery. NHS England specialised services are not the responsible commissioner for treatment of Lyme disease: Lyme disease is diagnosed and treated in primary care or in clinical commissioning groups’ infectious diseases hospital services according to the Prescribed Services Manual.</p><p> </p><p>The Department has funded four independent systematic reviews, published at the end of 2017, to further strengthen the evidence base for epidemiology, diagnosis, treatment and prevention of Lyme disease. The National Institute for Health and Care Excellence has recently published its clinical guideline on Lyme disease, which provides the latest information for clinicians in diagnosing and managing Lyme disease. The guideline aims to raise awareness of when Lyme disease should be considered and to ensure that people have prompt and consistent diagnosis and treatment.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/04/2018 16:51:22 answering member 4067 label Biography information for Steve Brine
tabling member	1408 label Biography information for Lord Swire

882153

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the use of personal fitness trackers on the prevention of cardio-vascular conditions.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	135212
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England is working with the National Institute for Health Research, Public Health England and the National Institute for Health and Care Excellence amongst others to develop suitable evidence generation plans for digital health tools, which will include wearables. Evaluation and evidence gathering is included as part of relevant programmes to help build the currently immature evidence pool in this space.</p><p> </p><p>NHS England and partner organisations have also established assessment criteria for digital tool developers looking at the quality, safety and effectiveness of digital health and care apps or tools. The service is due to go live towards the end of 2018 on the developer apps section of the National Health Service website.</p><p> </p><p>In addition, as part of the NHS Diabetes Prevention Programme, NHS England has pilots in hand to test the effectiveness of digital apps in supporting diabetes prevention, which are due to report by the end of 2019. They include consideration of the use of wearable technologies and fitness apps in supporting reduction of diabetes risk. It should be noted that many of the potential benefits of the NHS Diabetes Prevention Programme lie in reducing future cardiovascular events.</p><p> </p><p>Cardiovascular disease prevention is also a key theme in NHS England’s Five Year Forward View and their NHS RightCare programme, and both NHS England and Public Health England already have a number of initiatives in place in line with this aim, including the Cardiovascular Disease Prevention Optimal Value Pathway, cross-cutting interventions such as the NHS Health Check, and a new drive announced in September 2017 to prevent heart attacks and strokes by taking a more integrated approach to cardiovascular care.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:49:51 answering member 4067 label Biography information for Steve Brine
tabling member	3939 label Biography information for Andrew Percy

882154

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nutrition
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that clinical commissioning groups provide access to medical nutrition for all patients in their area for whom it is recommended by clinical guidelines.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	135213
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England published guidance on ‘Commissioning excellent nutrition and hydration’ in October 2015. This can be found at:</p><p> </p><p><a href="https://www.england.nhs.uk/commissioning/nut-hyd/" target="_blank">https://www.england.nhs.uk/commissioning/nut-hyd/</a></p><p> </p><p>NHS England has no plans to issue any further guidance at this time.</p><p> </p><p>The implementation of this guidance is a matter for the local National Health Service. NHS England has advised that no broader assessment has been made of the merits of integrating nutrition and hydration into clinical pathways for patients or the potential savings to the public purse from the integration of nutrition and hydration into clinical pathways.</p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 135218 135219 question first answered 23/04/2018 15:48:24 answering member 4067 label Biography information for Steve Brine
tabling member	3939 label Biography information for Andrew Percy